RNAC   $22.88  5.44% Market Closed

Cartesian Therapeutics Inc
Total Cash 87.23M
totalCashPerShare 4.079
EBITDA -35.35M
Total Debt 14.87M
quickRatio 4.7
currentRatio 4.778
Total Revenue 54.10M
debtToEquity
Revenue/Share 6.64
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -62.86M
earningsGrowth
revenueGrowth 5.372
grossMargins 0.04935
ebitdaMargins -0.65336
operatingMargins 0.41132998
profitMargins 0.0
enterpriseValue 395.49M
forwardPE -6.3604646
floatShares 8.61M
sharesOutstanding 23.90M
sharesShort 2.06M
sharesShortPriorMonth 2.01M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.56%
heldPercentInstitutions 0.24%
Short Ratio help_outline 27.03%
shortPercentOfFloat 0.14%
impliedSharesOutstanding
bookValue -5.695
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -267.20M
trailingEps -47.22%
forwardEps -3.44%
enterpriseToEbitda -11.19
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.73 3Q 2024
institutionsCount 87
lastUpdated Oct. 17, 2024, 12:49 p.m.